In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems

International Journal of Pharmaceutics

Volumn 417, Issue 1-2, 2011, Pages 245-255

  Larsen, Anne T ^a   Sassene, Philip ^a   Müllertz, Anette ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bile acids; Cryo TEM; Gastric lipase; In vitro lipolysis; Lipids; LSBDDS; PLM; SAXS; XRPD

Indexed keywords

BILE ACID; BILE ACID CONJUGATE; BILE EXTRACT; CALCIUM; CHOLESTEROL ESTERASE; CINNARIZINE; CREMOPHOR; DANAZOL; FATTY ACID; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; LIPID; OLEIC ACID; PANCREATIN; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROBUCOL; SESAME SEED OIL; SURFACTANT; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ARTICLE; BILE SECRETION; BIOCHEMICAL COMPOSITION; CRYOGENIC TRANSMISSION ELECTRON MICROSCOPY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PELLET; DRUG SOLUBILITY; DUODENUM; DYNAMIC LIGHT SCATTERING; GALLBLADDER; GASTROINTESTINAL TRACT; HUMAN; HYDRODYNAMICS; IN VITRO STUDY; INTESTINE FLUID; JEJUNUM; LIGHT SCATTERING; LIPOLYSIS; MICELLE; MICROSCOPY; NONHUMAN; POLARIZED LIGHT MICROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLUBILIZATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; LIPOLYSIS; SURFACE-ACTIVE AGENTS;

EID: 80052265520     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.002     Document Type: Article

References (71)

1. F.J. Alvarez, and V.J. Stella The role of calcium ions and bile salts on the pancreatic lipase-catalyzed hydrolysis of triglyceride emulsions stabilized with lecithin Pharm. Res. 6 1989 449 457
2. D. Alvaro, A. Cantafora, A.F. Attili, C.S. Ginanni, C. De Luca, G. Minervini, A. Di Biase, and M. Angelico Relationships between bile salts hydrophilicity and phospholipid composition in bile of various animal species Comp. Biochem. Physiol. B 83 1986 551 554
3. N. Anton, and T.F. Vandamme Nano-emulsions and micro-emulsions: clarifications of the critical differences Pharm. Res. 2010 10.1007/s11095-010- 0309-1
4. M. Armand, P. Borel, P. Ythier, G. Dutot, C. Melin, M. Senft, H. Lafont, and D. Lairon Effects of droplet size triacylglycerol composition, and calcium on the hydrolysis of complex emulsions by pancreatic lipase - an in vitro study J. Nutr. Biochem. 3 1992 333 341
5. J.R. Bellare, H.T. Davis, L.E. Scriven, and Y. Talmon Controlled environment vitrification system: an improved sample preparation technique J. Electron Microsc. Tech. 10 1988 87 111
6. E. Bergman, P. Forsell, A. Tevell, E.M. Persson, M. Hedeland, U. Bondesson, L. Knutson, and H. Lennernas Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase Eur. J. Pharm. Sci. 29 2006 205 214 (Pubitemid 44602407)
7. S. Bernback, L. Blackberg, and O. Hernell The complete digestion of human-milk triacylglycerol in vitro requires gastric lipase pancreatic colipase-dependent lipase, and bile-salt stimulated lipase J. Clin. Invest. 85 1990 1221 1226 (Pubitemid 20123766)
8. L. Blackberg, O. Hernell, G. Bengtsson, and T. Olivecrona Colipase enhances hydrolysis of dietary triglycerides in the absence of bile salts J. Clin. Invest. 64 1979 1303 1308
9. P. Borel, M. Armand, P. Ythier, G. Dutot, C. Melin, M. Senft, H. Lafont, and D. Lairon Hydrolysis of emulsions with different triglycerides and droplet sizes by gastric lipase in-vitro - effect on pancreatic lipase activity J. Nutr. Biochem. 5 1994 124 133 (Pubitemid 2058426)
10. H. Brockman Colipase-induced reorganization of interfaces as a regulator of lipolysis Colloids Surf. B: Biointerfaces 26 2002 102 111 (Pubitemid 34792711)
11. J. Brouwers, J. Tack, F. Lammert, and P. Augustijns Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir J. Pharm. Sci. 95 2006 372 383 (Pubitemid 43241979)
12. M.C. Carey, D.M. Small, and C.M. Bliss Lipid digestion and absorption Annu. Rev. Physiol. 45 1983 651 677
13. F. Carriere, J.A. Barrowman, R. Verger, and R. Laugier Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans Gastroenterology 105 1993 876 888 (Pubitemid 23249500)
14. J.O. Christensen, K. Schultz, B. Mollgaard, H.G. Kristensen, and A. Mullertz Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols Eur. J. Pharm. Sci. 23 2004 287 296 (Pubitemid 39369884)
15. J.F. Cuine, C.L. McEvoy, W.N. Charman, C.W. Pouton, G.A. Edwards, H. Benameur, and C.J. Porter Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs J. Pharm. Sci. 97 2008 993 1010
16. A. Dahan, and A. Hoffman Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats Pharm. Res. 23 2006 2165 2174
17. A. Dahan, and A. Hoffman The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats Eur. J. Pharm. Biopharm. 67 2007 96 105 (Pubitemid 46991342)
18. W.G. Dai, L.C. Dong, X. Shi, J. Nguyen, J. Evans, Y. Xu, and A.A. Creasey Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME) J. Pharm. Sci. 96 2007 2957 2969 (Pubitemid 350221196)
19. J. Dubochet, M. Adrian, J.J. Chang, J.C. Homo, J. Lepault, A.W. McDowall, and P. Schultz Cryo-electron microscopy of vitrified specimens Q. Rev. Biophys. 21 1988 129 228
20. J.K. Embleton, and C.W. Pouton Structure and function of gastro-intestinal lipases Adv. Drug Deliv. Rev. 25 1997 15 32 (Pubitemid 27107788)
21. A. Fahr, and X. Liu Drug delivery strategies for poorly water-soluble drugs Expert Opin. Drug Deliv. 4 2007 403 416 (Pubitemid 47249138)
22. D.G. Fatouros, B. Bergenstahl, and A. Mullertz Morphological observations on a lipid-based drug delivery system during in vitro digestion Eur. J. Pharm. Sci. 31 2007 85 94 (Pubitemid 46660577)
23. D.G. Fatouros, G.R. Deen, L. Arleth, B. Bergenstahl, F.S. Nielsen, J.S. Pedersen, and A. Mullertz Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering Pharm. Res. 24 2007 1844 1853 (Pubitemid 47389238)
24. D.G. Fatouros, F.S. Nielsen, D. Douroumis, L.J. Hadjileontiadis, and A. Mullertz In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks Eur. J. Pharm. Biopharm. 69 2008 887 898
25. S. Fernandez, S. Chevrier, N. Ritter, B. Mahler, F. Demarne, F. Carriere, and V. Jannin In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients labrasol (R) and gelucire (R) 44/14 Pharm. Res. 26 2009 1901 1910
26. S. Fernandez, V. Jannin, J.D. Rodier, N. Ritter, B. Mahler, and F. Carriere Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol(R), medium chain glycerides and PEG esters Biochim. Biophys. Acta 1771 2007 633 640 (Pubitemid 46670793)
27. F.D. Gillin, S.E. Boucher, S.S. Rossi, and D.S. Reiner Giardia lamblia: the roles of bile, lactic acid, and pH in the completion of the life cycle in vitro Exp. Parasitol. 69 1989 164 174 (Pubitemid 19207941)
28. D. Giron, P. Remy, S. Thomas, and E. Vilette Quantitation of amorphicity by microcalorimetry J. Therm. Anal. 48 1997 465 472
29. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182 (Pubitemid 38479922)
30. B.C. Hancock, and M. Parks What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17 2000 397 404 (Pubitemid 30395293)
31. O. Hernell, J.E. Staggers, and M.C. Carey Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase-analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human-beings Biochemistry 29 1990 2041 2056 (Pubitemid 20085429)
32. L. Kalantzi, K. Goumas, V. Kalioras, B. Abrahamsson, J.B. Dressman, and C. Reppas Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies Pharm. Res. 23 2006 165 176 (Pubitemid 43214673)
33. a of long-chain fatty acids J. Colloid Interface Sci. 256 2002 201 207 (Pubitemid 36164593)
34. A.M. Kaukonen, B.J. Boyd, W.N. Charman, and C.J.H. Porter Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids Pharm. Res. 21 2004 254 260 (Pubitemid 38221970)
35. A.M. Kaukonen, B.J. Boyd, C.J.H. Porter, and W.N. Charman Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations Pharm. Res. 21 2004 245 253 (Pubitemid 38221969)
36. K. Kleberg, F. Jacobsen, D.G. Fatouros, and A. Mullertz Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity J. Pharm. Sci. 99 2010 3522 3532
37. K. Kleberg, J. Jacobsen, and A. Mullertz Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies J. Pharm. Pharmacol. 62 2010 1656 1668
38. G.A. Kossena, B.J. Boyd, C.J. Porter, and W.N. Charman Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs J. Pharm. Sci. 92 2003 634 648 (Pubitemid 36258978)
39. G.A. Kossena, W.N. Charman, B.J. Boyd, D.E. Dunstan, and C.J.H. Porter Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach J. Pharm. Sci. 93 2004 332 348 (Pubitemid 38174256)
40. G.A. Kossena, W.N. Charman, B.J. Boyd, and C.J. Porter Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug J. Pharm. Sci. 94 2005 481 492 (Pubitemid 40476514)
41. A. Larsen, R. Holm, M.L. Pedersen, and A. Mullertz Lipid-based formulations for danazol containing a digestible surfactant labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis Pharm. Res. 2008
42. A. Larsen, L. Jensen, K. Kleberg, and A. Mullertz Selection of a lipase for development of an in vitro gastric lipid digestion model Poster presented at American Association of Pharmaceutical Scientists Annual Meeting New Orleans, LA, USA. 2010
43. A. Lindahl, A.L. Ungell, L. Knutson, and H. Lennernas Characterization of fluids from the stomach and proximal jejunum in men and women Pharm. Res. 14 1997 497 502 (Pubitemid 27205011)
44. K.J. MacGregor, J.K. Embleton, J.E. Lacy, E.A. Perry, L.J. Solomon, H. Seager, and C.W. Pouton Influence of lipolysis on drug absorption from the gastro-intestinal tract Adv. Drug Deliv. Rev. 25 1997 33 46 (Pubitemid 27107789)
45. K. Mohsin, M.A. Long, and C.W. Pouton Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution J. Pharm. Sci. 98 2009 3582 3595
46. A. Mullertz, A. Ogbonna, S. Ren, and T. Rades New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs J. Pharm. Pharmacol. 62 2010 1622 1636
47. J.S. Patton, and M.C. Carey Watching fat digestion Science 204 1979 145 148
48. J.S. Patton, and M.C. Carey Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles Am. J. Physiol. 241 1981 G328 G336
49. C.M. Perez de la, M. Oth, S. Deferme, F. Lammert, J. Tack, J. Dressman, and P. Augustijns Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum J. Pharm. Pharmacol. 58 2006 1079 1089 (Pubitemid 44213641)
50. E.M. Persson, A.S. Gustafsson, A.S. Carlsson, R.G. Nilsson, L. Knutson, P. Forsell, G. Hanisch, H. Lennernas, and B. Abrahamsson The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids Pharm. Res. 22 2005 2141 2151 (Pubitemid 41821594)
51. E.M. Persson, R.G. Nilsson, G.I. Hansson, L.J. Lofgren, F. Liback, L. Knutson, B. Abrahamsson, and H. Lennernas A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine Pharml. Res. 23 2006 742 751
52. C.J.H. Porter, and W.N. Charman In vitro assessment of oral lipid based formulations Adv. Drug Deliv. Rev. 50 2001 127 147
53. C.J.H. Porter, A.M. Kaukonen, B.J. Boyd, G.A. Edwards, and W.N. Charman Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation Pharm. Res. 21 2004 1405 1412 (Pubitemid 39149655)
54. C.J.H. Porter, A.M. Kaukonen, A. Taillardat-Bertschinger, B.J. Boyd, J.M. O'Connor, G.A. Edwards, and W.N. Charman Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine J. Pharm. Sci. 93 2004 1110 1121 (Pubitemid 38529685)
55. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S93 S98
56. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. 29 2006 278 287 (Pubitemid 44740131)
57. J.P. Reymond, and H. Sucker In vitro model for ciclosporin intestinal absorption in lipid vehicles Pharm. Res. 5 1988 673 676 (Pubitemid 18263617)
58. G.D. Roshan, A.E. Aagaard, J.S. Pedersen, D.G. Fatouros, and A. Mullertz Experimental Set-up with flow-through cell with SAXS studies of in-situ degradation of drug formulations under gastro-intestinal mimicking conditions 13th international conference of Small Angle Scattering Kyoto, Japan 2006
59. P.J. Sassene, M.M. Knopp, J.Z. Hesselkilde, V. Koradia, A. Larsen, T. Rades, and A. Mullertz Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate J. Pharm. Sci. 99 2010 4982 4991
60. Sassene, P.J., Larsen, A., Koradia, V., Rades, T., Mullertz, A. Precipitation of three poorly soluble model drugs during in vitro lipolysis: characterization and dissolution of the precipitate, in preparation.
61. C. Seadeek, H. Ando, S.N. Bhattachar, T. Heimbach, J.L. Sonnenberg, and A.C. Blackburn Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds J. Pharm. Biomed. Anal. 43 2007 1660 1666 (Pubitemid 46453084)
62. L. Sek, C.J. Porter, and W.N. Charman Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis J. Pharm. Biomed. Anal. 25 2001 651 661 (Pubitemid 32493922)
63. L. Sek, C.J. Porter, A.M. Kaukonen, and W.N. Charman Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products J. Pharm. Pharmacol. 54 2002 29 41 (Pubitemid 34116220)
64. E. Soderlind, E. Karlsson, A. Carlsson, R. Kong, A. Lenz, S. Lindborg, and J.J. Sheng Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids Mol. Pharm. 2010 DOI: 10.1021/mp100144v
65. J.E. Staggers, O. Hernell, R.J. Stafford, and M.C. Carey Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase-behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human-beings Biochemistry 29 1990 2028 2040 (Pubitemid 20085428)
66. A. Tangerman, A. Vanschaik, and E.W. Vanderhoek Analysis of conjugated and unconjugated bile-acids in serum and jejunal fluid of normal subjects Clin. Chim. Acta 159 1986 123 132 (Pubitemid 16033046)
67. USP33 Pancreatin monograph (8049-47-6), 2010. The United States Pharmacopeia/The National Formulary (USP33/NF28) 2010. United States Pharmacopoeial Convention, Inc., Rockville, MD, USA.
68. M. Wickham, M. Garrood, J. Leney, P.D.G. Wilson, and A. Fillery-Travis Modification of a phospholipid stabilized emulsion interface by bile salt: effect on pancreatic lipase activity J. Lipid Res. 39 1998 623 632 (Pubitemid 28158404)
69. N. Wyttenbach, J. Alsenz, and O. Grassmann Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development Pharm. Res. 24 2007 888 898 (Pubitemid 46675389)
70. N.H. Zangenberg, A. Mullertz, H.G. Kristensen, and L. Hovgaard A dynamic in vitro lipolysis model I. Controlling the rate of lipolysis by continuous addition of calcium Eur. J. Pharm. Sci. 14 2001 115 122 (Pubitemid 32737533)
71. N.H. Zangenberg, A. Mullertz, H.G. Kristensen, and L. Hovgaard A dynamic in vitro lipolysis model II: evaluation of the model Eur. J. Pharm. Sci. 14 2001 237 244 (Pubitemid 32884320)